Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy (2015)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; DUARTE, GERALDO - FMRP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1038/hr.2015.15
- Subjects: PRÉ-ECLÂMPSIA; HIPERTENSÃO NA GRAVIDEZ; GESTANTES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Hypertension Research
- ISSN: 0916-9636
- Volume/Número/Paginação/Ano: v. 38, n. 5, p. 361-366, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
LUIZON, Marcelo R. et al. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy. Hypertension Research, v. 38, n. 5, p. 361-366, 2015Tradução . . Disponível em: https://doi.org/10.1038/hr.2015.15. Acesso em: 28 abr. 2024. -
APA
Luizon, M. R., Belo, V. A., Palei, A. C. T., Amaral, L. M., Lacchini, R., Sandrim, V. C., et al. (2015). Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy. Hypertension Research, 38( 5), 361-366. doi:10.1038/hr.2015.15 -
NLM
Luizon MR, Belo VA, Palei ACT, Amaral LM, Lacchini R, Sandrim VC, Duarte G, Cavalli R de C, Tanus-Santos JE. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy [Internet]. Hypertension Research. 2015 ; 38( 5): 361-366.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1038/hr.2015.15 -
Vancouver
Luizon MR, Belo VA, Palei ACT, Amaral LM, Lacchini R, Sandrim VC, Duarte G, Cavalli R de C, Tanus-Santos JE. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy [Internet]. Hypertension Research. 2015 ; 38( 5): 361-366.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1038/hr.2015.15 - Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
- Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
- Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- eNOS tag SNP haplotypes in hypertensive disorders of pregnancy
- Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia
- Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period
- Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy
Informações sobre o DOI: 10.1038/hr.2015.15 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas